Distinct Patterns of Daily Glucose Variability by Pubertal Status in Youth With Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate glycemia and metrics of glucose variability in youth with type 1 diabetes, and to assess patterns of 24-h glucose variability according to pubertal status. RESEARCH DESIGN AND METHODS: Metrics of glycemia, glucose variability, and glucose patterns were assessed by using 4 weeks of continuous glucose monitoring (CGM) data from 107 youth aged 8–17 years with type 1 diabetes for ≥1 year. Glucose values per hour were expressed as percentages relative to the mean glucose over 24 h for a 4-week period. Glucose data were compared on the basis of pubertal status—prepubertal (Tanner stage [T] 1), pubertal (T2–4), and postpubertal (T5)—and A1C categories (<7.5% [<58 mmol/mol], ≥7.5% [≥58 mmol/mol]). RESULTS: Youth (50% female, 95% white) had a mean ± SD age of 13.1 ± 2.6 years, diabetes duration of 6.3 ± 3.5 years, and A1C of 7.8 ± 0.8% (62 ± 9 mmol/mol); 88% were pump treated. Prepubertal youth had a higher mean glucose SD (86 ± 12 mg/dL [4.8 ± 0.7 mmol/L]; P = 0.01) and coefficient of variation (CV) (43 ± 5%; P = 0.06) than did pubertal (SD 79 ± 13 mg/dL [4.4 ± 0.7 mmol/L]; CV 41 ± 5%) and postpubertal (SD 77 ± 14 mg/dL [4.3 ± 0.8 mmol/L]; CV 40 ± 5%) youth. Over 24 h, prepubertal youth had the largest excursions from mean glucose and the highest CV across most hours compared with pubertal and postpubertal youth. Across all youth, CV was strongly correlated with the percentage of time with glucose <70 mg/dL (<3.9 mmol/L) (r = 0.79; P < 0.0001). CONCLUSIONS: Prepubertal youth had greater glucose variability independent of A1C than did pubertal and postpubertal youth. A1C alone does not capture the full range of glycemic parameters, highlighting the added insight of CGM in managing youth with type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“High coefficient of variation (>36%) has also been related to occurrence of hypoglycemia (32).”
From 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026. (2026) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000
Kuczmarski, R. J., Ogden, C. L., Guo, S. S., Strawn, L. G., Flegal, K. M., & Mei, Z. (2002) · Cited by 6,426
2000 CDC Growth Charts for the United States: methods and development.
Kuczmarski, R. J., Ogden, C. L., Guo, S. S., Grummer‐Strawn, L. M., Flegal, K. M., Mei, Z., Wei, R. X., Curtin, L. R., Roche, A. F., & Johnson, C. L. (2002) · PubMed · Cited by 3,716
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · cited 3×
“Discrepancies between mean glucose and A1C could be attributed to differences in red blood cell turnover rates and/or differences in glycation rates (15).”
BackgroundSelf-citationMiller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V. (2015) · Diabetes Care · doi:10.2337/dc15-0078 · Cited by 1,254
Impaired Insulin Action in Puberty
Amiel, S. A., Sherwin, R. S., Simonson, D. C., Lauritano, A. A., & Tamborlane, W. V. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607243150402 · Cited by 958
Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities
Rodbard, D. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0417 · Cited by 737
DiMeglio, L. A., Acerini, C. L., Codner, E., Craig, M. E., Hofer, S. E., Pillay, K., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12737 · Cited by 604
The relationships between time in range, hyperglycemia metrics, and HbA1c
Beck, R. W., Bergenstal, R. M., Cheng, P., Kollman, C., Carlson, A. L., Johnson, M. L., & Rodbard, D. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818822496 · Cited by 479
The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading
Beck, R. W., Connor, C. G., Mullen, D. M., Wesley, D. M., & Bergenstal, R. M. (2017) · Diabetes Care · doi:10.2337/dc17-0636 · Cited by 477
Wood, J. R., Miller, K. M., Maahs, D. M., Beck, R. W., DiMeglio, L. A., Libman, I. M., Quinn, M., Tamborlane, W. V., Woerner, S. E., & for the T1D Exchange Clinic Network (2013) · Diabetes Care · doi:10.2337/dc12-1959 · Cited by 415
Cited by
6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s006 · Cited by 172
Self-citationUnderstanding temporal changes and seasonal variations in glycemic trends using wearable data
Belsare, P. V., Bartolome, A., Stanger, C., & Prioleau, T. (2023) · Science Advances · doi:10.1126/sciadv.adg2132 · Cited by 31
DiMeglio, L. A., Kanapka, L. G., DeSalvo, D. J., Anderson, B. J., Harrington, K. R., Hilliard, M. E., Laffel, L. M., Tamborlane, W. V., Name, M. A. V., Wadwa, R. P., et al. (2020) · Diabetic Medicine · doi:10.1111/dme.14276 · Cited by 25
Self-citationPiona, C. A., Marigliano, M., Mozzillo, E., Rosanio, F. M., Zanfardino, A., Iafusco, D., Maltoni, G., Zucchini, S., Piccinno, E., Delvecchio, M., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108933 · Cited by 25
AlBabtain, S. A., Alafif, N. O., Aldisi, D. A., & ALZAHRANI, S. H. (2023) · Healthcare · doi:10.3390/healthcare11070934 · Cited by 17
Piona, C. A., Marigliano, M., Mozzillo, E., Candia, F. D., Zanfardino, A., Iafusco, D., Maltoni, G., Zucchini, S., Delvecchio, M., & Maffeis, C. (2021) · Hormone Research in Paediatrics · doi:10.1159/000521430 · Cited by 17
Putting Continuous Glucose Monitoring to Work for People With Type 1 Diabetes
Hood, K. K., DiMeglio, L. A., & Riddle, M. C. (2019) · Diabetes Care · doi:10.2337/dci19-0054 · Cited by 16
Use of continuous glucose monitoring trend arrows in the younger population with type 1 diabetes
Elbarbary, N. S., Moser, O., Al-Yaarubi, S., Alsaffar, H., Shaikh, A. M. A., Ajjan, R., & Deeb, A. (2021) · Diabetes and Vascular Disease Research · doi:10.1177/14791641211062155 · Cited by 16
Bombaci, B., Passanisi, S., Lombardo, F., & Salzano, G. (2024) · Translational Pediatrics · doi:10.21037/tp-24-114 · Cited by 12
Biester, T., Grimsmann, J. M., Heidtmann, B., Rami-Merhar, B. M., Ermer, U., Wolf, J., Freff, M., Karges, B., Agena, D., Bramlage, P., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0373 · Cited by 13
Randazzese, S. F., Bombaci, B., Costantino, S., Giorgianni, Y., Lombardo, F., & Salzano, G. (2024) · Children · doi:10.3390/children11020210 · Cited by 12
Boggiss, A. L., Babbott, K. M., Milford, Ā., Ellett, S. G., Consedine, N. S., Reid, S., Cao, N., Cavadino, A., Hopkins, S. A., Jefferies, C., et al. (2025) · Diabetic Medicine · doi:10.1111/dme.70115 · Cited by 10
Dingena, C. F., Holmes, M. J., Campbell, M. D., Cade, J. E., SCOTT, E. M., & Zulyniak, M. A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1065985 · Cited by 8
Tienhaara, E., Falck, A. A. K., Pokka, T. M.-L., & Tossavainen, P. H. (2021) · Diabetic Medicine · doi:10.1111/dme.14732 · Cited by 8
Treatment of cardiometabolic risk factors in patients with type 1 diabetes
Niechciał, E., & Marcovecchio, M. L. (2020) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000915 · Cited by 7
Ray, M. K., McMichael, A., Rivera-Santana, M. V., Noel, J., & Hershey, T. G. (2021) · JMIR Diabetes · doi:10.2196/27027 · Cited by 6
Zhao, G., Yu, X., Wang, L., Jin, Y., Yang, A., Sun, F., Wang, X., Jing, X., & Gao, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-45846-1 · Cited by 4
Beyond A1C: A Practical Approach to Interpreting and Optimizing Continuous Glucose Data in Youth
Al-Gadi, I., Menon, S., Lyons, S. K., & DeSalvo, D. J. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0095 · Cited by 4
Grotta, R. L., Pellegrini, V., Carreras, F., Berra, C., Mužina, K., Bizjan, B. J., Dovč, K., Prattichizzo, F., Battelino, T., & Ceriello, A. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02983-3 · Cited by 3
Heald, A. H., Stedman, M., Warner-Levy, J. J., Belston, L., Paisley, A. N., Jotić, A., Lalic, N. M., Gibson, M., Habte‐Asres, H. H., Whyte, M., et al. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01647-x · Cited by 3
Sklar, J., Volkening, L. K., TINSLEY, L. J., & Laffel, L. M. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0233 · Cited by 3
Self-citationNjateng, G. S. S., Ganita, K., & Yousuf, S. (2024) · Cureus · doi:10.7759/cureus.58082 · Cited by 2
Dong, L., Li, J., Hu, Y., Chai, R., Zhu, Y. F., Zhu, L., Fan, N., Zhang, Z., Pan, J., Yan, J., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1464755 · Cited by 1
Gera, S., Rearson, A., Gallop, R., & Marks, B. E. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0173 · Cited by 1
FEAR OF HYPOGLYCEMIA IN TYPE 1 DIABETES MELLITUS
Markanovic, H. (2021)
Shestakova, M. V., Peterkova, V. A., Galstyan, G. R., Ibragimova, L. I., Klimontov, V. V., Лаптев, Д. Н., Malaya, I. P., & Shestakova, E. A. (2025) · Diabetes Mellitus · doi:10.14341/dm13329
Guilmin‐Crépon, S. (2019) · theses.fr (ABES) · doi:10.70675/5899a8c0z309fz4054zb769z5131506531f0
Cinar, B., & Maleshkova, M. (2026) · IEEE Conference on Artificial Intelligence (CAI) · doi:10.1109/cai68641.2026.11536643
Booijink, R. S., de Haan, J. S., van den Berg, L., Jansen, T. J. P., Neijens, F. S., & van Bon, A. C. (2026) · Pediatric Diabetes · doi:10.48130/pedi-0026-0009
Continuous glucose monitoring devices in hospitalized pediatric patients
Mensah, I. K., & Farnsworth, C. W. (2026) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2026.2722682
Flabe, A. H., Zabeen, B., Amirat, S., & Luo, J. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70347
Leung, J. M. W. S., Braschel, M. C., Bone, J. N., & Amed, S. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-122858
Metadata
- Authors
- Zhu, J., Volkening, L. K., & Laffel, L. M.
- Affiliations
- Boston Children's Hospital (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Laffel, Lori M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-07-15
- Volume
- 43
- Issue
- 1
- Pages
- 22-28
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC6925575
- OpenAlex
- W2961590930
- Semantic Scholar
- 5167023ad75809d499fad91aff85235935fd6087
- Cited by
- 30
- References
- 43
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 5 · 2023: 4 · 2021: 7 · 2020: 3 · 2019: 1
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Diabetes Care (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R01DK089349, K12DK094721, P30DK036836)
- Eleanor Chesterman Beatson Fund
- Maria Griffin Drury Pediatric Fund
- Katherine Adler Astrove Youth Education Fund
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 1 diabetes, youth, pubertal stage, glycemic variability, continuous glucose monitoring, prepubertal children, glycemic control, HbA1c, glycemic excursions, insulin therapy, sex differences, HbA1c thresholds, glycemic targets
- MeSH terms
- Biological Variation, Population, Adolescent, Blood Glucose, Child, Diabetes Mellitus, Type 1, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Male, Puberty, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.